Clinical trial
Efficacy Study of Clevidipine Assessing Its Preoperative Antihypertensive Effect in Cardiac Surgery (ESCAPE-1)
NCT00093249 is registered in ClinicalTrials.gov with The Medicines Company as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Efficacy Study of Clevidipine Assessing Its Preoperative Antihypertensive Effect in Cardiac Surgery (ESCAPE-1)
- Lead sponsor
- The Medicines Company
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- January 31, 2004
- Completion date
- November 30, 2004
- Enrollment
- 105 (actual)
- Sites
- 12
Conditions
As the registry lists them; a condition with its own page is linked.